Coloplast A/S is trading at 83.42 as of the 29th of January 2026. This is a 0.95 percent down since the beginning of the trading day. The stock's lowest day price was 83.42. Coloplast A/S has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of October 2025 and ending today, the 29th of January 2026. Click here to learn more.
Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.. The company has 194.31 M outstanding shares. More on Coloplast AS
Coloplast AS [CLPBF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 24.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast A/S's market, we take the total number of its shares issued and multiply it by Coloplast A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast A/S classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 194.31 M outstanding shares.
Coloplast AS has accumulated about 854 M in cash with 5.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.02.
Check Coloplast A/S Probability Of BankruptcyOwnership AllocationColoplast A/S holds a total of 194.31 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Coloplast Ownership Details
About 35.0% of the company shares are held by company insiders. The company last dividend was issued on the 2nd of December 2022. Coloplast A/S had 5:1 split on the 19th of December 2012. Coloplast AS engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast is traded on OTC Exchange in the United States.The quote for Coloplast AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Coloplast AS please contact the company at 45 49 11 11 11 or go to https://www.coloplast.com.
Coloplast A/S Investment Alerts
Coloplast A/S generated a negative expected return over the last 90 days
About 35.0% of the company shares are held by company insiders
Coloplast Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 24.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast A/S's market, we take the total number of its shares issued and multiply it by Coloplast A/S's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Coloplast Profitablity
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.
Technical Drivers
As of the 29th of January, Coloplast A/S shows the Mean Deviation of 1.64, risk adjusted performance of (0.02), and Standard Deviation of 2.68. Coloplast A/S technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Coloplast A/Sstandard deviation, treynor ratio, as well as the relationship between the Treynor Ratio and potential upside to decide if Coloplast A/S is priced correctly, providing market reflects its regular price of 83.42 per share. Given that Coloplast A/S has information ratio of (0.06), we suggest you to validate Coloplast AS's prevailing market performance to make sure the company can sustain itself at a future point.
The output start index for this execution was zero with a total number of output elements of sixty-one. Coloplast A/S Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Coloplast A/S price patterns.
Coloplast A/S Predictive Daily Indicators
Coloplast A/S intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Coloplast A/S pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Coloplast A/S's time-series forecasting models are one of many Coloplast A/S's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coloplast A/S's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Coloplast A/S without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Forecasting Now
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Other Information on Investing in Coloplast Pink Sheet
Coloplast A/S financial ratios help investors to determine whether Coloplast Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast A/S security.